vs

Side-by-side financial comparison of Danaher Corporation (DHR) and EMCOR Group, Inc. (EME). Click either name above to swap in a different company.

Danaher Corporation is the larger business by last-quarter revenue ($6.0B vs $4.5B, roughly 1.3× EMCOR Group, Inc.). Danaher Corporation runs the higher net margin — 17.3% vs 9.6%, a 7.7% gap on every dollar of revenue. On growth, EMCOR Group, Inc. posted the faster year-over-year revenue change (19.7% vs 3.7%). Danaher Corporation produced more free cash flow last quarter ($1.1B vs $492.5M). Over the past eight quarters, EMCOR Group, Inc.'s revenue compounded faster (14.7% CAGR vs 1.8%).

Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments,...

EMCOR Group, Inc., is an engineering, construction, and property management company headquartered in Norwalk, Connecticut.

DHR vs EME — Head-to-Head

Bigger by revenue
DHR
DHR
1.3× larger
DHR
$6.0B
$4.5B
EME
Growing faster (revenue YoY)
EME
EME
+16.1% gap
EME
19.7%
3.7%
DHR
Higher net margin
DHR
DHR
7.7% more per $
DHR
17.3%
9.6%
EME
More free cash flow
DHR
DHR
$592.5M more FCF
DHR
$1.1B
$492.5M
EME
Faster 2-yr revenue CAGR
EME
EME
Annualised
EME
14.7%
1.8%
DHR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DHR
DHR
EME
EME
Revenue
$6.0B
$4.5B
Net Profit
$1.0B
$434.6M
Gross Margin
60.3%
19.7%
Operating Margin
22.6%
12.7%
Net Margin
17.3%
9.6%
Revenue YoY
3.7%
19.7%
Net Profit YoY
7.9%
48.8%
EPS (diluted)
$1.45
$9.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DHR
DHR
EME
EME
Q1 26
$6.0B
Q4 25
$6.8B
$4.5B
Q3 25
$6.1B
$4.3B
Q2 25
$5.9B
$4.3B
Q1 25
$5.7B
$3.9B
Q4 24
$6.5B
$3.8B
Q3 24
$5.8B
$3.7B
Q2 24
$5.7B
$3.7B
Net Profit
DHR
DHR
EME
EME
Q1 26
$1.0B
Q4 25
$1.2B
$434.6M
Q3 25
$908.0M
$295.4M
Q2 25
$555.0M
$302.2M
Q1 25
$954.0M
$240.7M
Q4 24
$1.1B
$292.2M
Q3 24
$818.0M
$270.3M
Q2 24
$907.0M
$247.6M
Gross Margin
DHR
DHR
EME
EME
Q1 26
60.3%
Q4 25
58.0%
19.7%
Q3 25
58.2%
19.4%
Q2 25
59.3%
19.4%
Q1 25
61.2%
18.7%
Q4 24
59.5%
20.1%
Q3 24
58.7%
19.9%
Q2 24
59.7%
18.7%
Operating Margin
DHR
DHR
EME
EME
Q1 26
22.6%
Q4 25
22.0%
12.7%
Q3 25
19.1%
9.4%
Q2 25
12.8%
9.6%
Q1 25
22.2%
8.2%
Q4 24
21.8%
10.3%
Q3 24
16.5%
9.8%
Q2 24
20.3%
9.1%
Net Margin
DHR
DHR
EME
EME
Q1 26
17.3%
Q4 25
17.5%
9.6%
Q3 25
15.0%
6.9%
Q2 25
9.3%
7.0%
Q1 25
16.6%
6.2%
Q4 24
16.6%
7.7%
Q3 24
14.1%
7.3%
Q2 24
15.8%
6.8%
EPS (diluted)
DHR
DHR
EME
EME
Q1 26
$1.45
Q4 25
$1.69
$9.64
Q3 25
$1.27
$6.57
Q2 25
$0.77
$6.72
Q1 25
$1.32
$5.26
Q4 24
$1.50
$6.30
Q3 24
$1.12
$5.80
Q2 24
$1.22
$5.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DHR
DHR
EME
EME
Cash + ST InvestmentsLiquidity on hand
$1.1B
Total DebtLower is stronger
Stockholders' EquityBook value
$3.7B
Total Assets
$9.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DHR
DHR
EME
EME
Q1 26
Q4 25
$1.1B
Q3 25
$655.1M
Q2 25
$486.0M
Q1 25
$576.7M
Q4 24
$1.3B
Q3 24
$1.0B
Q2 24
$807.3M
Total Debt
DHR
DHR
EME
EME
Q1 26
Q4 25
$18.4B
Q3 25
$16.9B
Q2 25
$17.4B
Q1 25
$16.5B
Q4 24
$16.0B
Q3 24
$17.5B
Q2 24
$17.0B
Stockholders' Equity
DHR
DHR
EME
EME
Q1 26
Q4 25
$52.5B
$3.7B
Q3 25
$51.1B
$3.3B
Q2 25
$52.3B
$3.1B
Q1 25
$50.8B
$2.9B
Q4 24
$49.5B
$2.9B
Q3 24
$51.3B
$2.8B
Q2 24
$49.9B
$2.7B
Total Assets
DHR
DHR
EME
EME
Q1 26
Q4 25
$83.5B
$9.3B
Q3 25
$79.9B
$8.6B
Q2 25
$81.6B
$8.4B
Q1 25
$79.1B
$8.1B
Q4 24
$77.5B
$7.7B
Q3 24
$80.6B
$7.3B
Q2 24
$78.6B
$7.1B
Debt / Equity
DHR
DHR
EME
EME
Q1 26
Q4 25
0.35×
Q3 25
0.33×
Q2 25
0.33×
Q1 25
0.32×
Q4 24
0.32×
Q3 24
0.34×
Q2 24
0.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DHR
DHR
EME
EME
Operating Cash FlowLast quarter
$1.3B
$524.4M
Free Cash FlowOCF − Capex
$1.1B
$492.5M
FCF MarginFCF / Revenue
18.2%
10.9%
Capex IntensityCapex / Revenue
4.0%
0.7%
Cash ConversionOCF / Net Profit
1.28×
1.21×
TTM Free Cash FlowTrailing 4 quarters
$5.3B
$1.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DHR
DHR
EME
EME
Q1 26
$1.3B
Q4 25
$2.1B
$524.4M
Q3 25
$1.7B
$475.5M
Q2 25
$1.3B
$193.7M
Q1 25
$1.3B
$108.5M
Q4 24
$2.0B
$469.5M
Q3 24
$1.5B
$526.4M
Q2 24
$1.4B
$279.7M
Free Cash Flow
DHR
DHR
EME
EME
Q1 26
$1.1B
Q4 25
$1.7B
$492.5M
Q3 25
$1.4B
$448.8M
Q2 25
$1.1B
$165.6M
Q1 25
$1.1B
$82.3M
Q4 24
$1.5B
$451.8M
Q3 24
$1.2B
$508.7M
Q2 24
$1.1B
$260.4M
FCF Margin
DHR
DHR
EME
EME
Q1 26
18.2%
Q4 25
25.5%
10.9%
Q3 25
22.6%
10.4%
Q2 25
18.4%
3.8%
Q1 25
18.4%
2.1%
Q4 24
23.0%
12.0%
Q3 24
21.0%
13.8%
Q2 24
19.7%
7.1%
Capex Intensity
DHR
DHR
EME
EME
Q1 26
4.0%
Q4 25
5.4%
0.7%
Q3 25
4.8%
0.6%
Q2 25
4.2%
0.7%
Q1 25
4.3%
0.7%
Q4 24
7.9%
0.5%
Q3 24
5.1%
0.5%
Q2 24
5.0%
0.5%
Cash Conversion
DHR
DHR
EME
EME
Q1 26
1.28×
Q4 25
1.77×
1.21×
Q3 25
1.83×
1.61×
Q2 25
2.41×
0.64×
Q1 25
1.36×
0.45×
Q4 24
1.86×
1.61×
Q3 24
1.85×
1.95×
Q2 24
1.56×
1.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons